Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/. Accessed 12 May 2024.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/. Accessed May 12, 2024.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/
Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
ID - 435694
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/
DB - Evidence Central
DP - Unbound Medicine
ER -